WallStSmart
ACAD

ACADIA Pharmaceuticals Inc

NASDAQ: ACAD · HEALTHCARE · BIOTECHNOLOGY

$22.20
-2.07% today

Updated 2026-04-29

Market cap
$3.80B
P/E ratio
9.65
P/S ratio
3.55x
EPS (TTM)
$2.30
Dividend yield
52W range
$14 – $28
Volume
1.9M

ACADIA Pharmaceuticals Inc (ACAD) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$8.13M$7.55M$1.59M$6.40M$42.13M$2.07M$4.91M$1.15M$120000.00$61000.00$17.33M$124.90M$223.81M$339.08M$441.75M$484.14M$517.24M$726.44M$957.80M$1.07B
Revenue growth (YoY)-7.1%-79.0%+302.5%+558.5%-95.1%+137.4%-76.7%-89.5%-49.2%+28311.5%+620.7%+79.2%+51.5%+30.3%+9.6%+6.8%+40.4%+31.8%+11.9%
Cost of revenue$59.90M$69.14M$65.37M$49.47M$26.43M$23.53M$25.68M$26.72M$93.14M$2.50M$4.41M$13.06M$18.33M$19.60M$20.55M$19.14M$10.17M$45.73M$81.84M$89.00M
Gross profit$8.13M$7.55M$1.59M$6.40M$42.13M$2.07M$4.91M$-25.58M$120000.00$61000.00$12.93M$111.84M$205.48M$319.48M$421.20M$465.00M$507.07M$680.71M$875.96M$982.51M
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%-2233.8%100.0%100.0%74.6%89.5%91.8%94.2%95.3%96.0%98.0%93.7%91.5%91.7%
R&D$49.40M$57.94M$56.75M$41.59M$20.58M$17.31M$18.79M$26.72M$60.60M$73.87M$99.28M$149.19M$187.16M$240.38M$319.13M$239.41M$361.57M$351.62M$303.25M$328.80M
SG&A$11.35M$12.27M$11.82M$10.28M$6.46M$7.61M$7.00M$12.72M$32.75M$90.80M$186.46M$255.06M$265.76M$325.64M$388.66M$396.03M$369.09M$393.07M$488.43M$548.89M
Operating income$-49.05M$-62.65M$-66.98M$-45.47M$15.09M$-22.85M$-20.89M$-38.30M$-93.23M$-164.61M$-272.81M$-292.41M$-247.44M$-246.54M$-286.59M$-170.44M$-223.60M$-73.38M$230.79M$104.81M
Operating margin-603.1%-829.3%-4212.5%-710.5%35.8%-1105.6%-425.6%-3344.7%-77691.7%-269855.7%-1574.1%-234.1%-110.6%-72.7%-64.9%-35.2%-43.2%-10.1%24.1%9.8%
EBITDA$-49.05M$-62.65M$-65.94M$-44.36M$15.70M$-22.48M$-20.78M$-38.22M$-93.02M$-163.97M$-270.99M$-289.70M$-244.44M$-243.78M$-283.65M$-167.09M$-221.57M$-67.83M$100.16M$138.90M
EBITDA margin-603.1%-829.3%-4146.9%-693.2%37.3%-1087.6%-423.4%-3337.8%-77520.0%-268795.1%-1563.6%-231.9%-109.2%-71.9%-64.2%-34.5%-42.8%-9.3%10.5%13.0%
EBIT$-48.91M$-63.42M$-66.98M$-45.47M$15.09M$-22.77M$-20.89M$-38.30M$-93.23M$-164.61M$-272.81M$-292.41M$-247.44M$-246.54M$-286.59M$-170.44M$-223.60M$-73.38M$84.28M
Interest expense$198000.00$268000.00$181000.00$86000.00$37000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$14.93M$8.54M$6.26M$6.61M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-45.05M$-56.39M$-64.24M$-45.15M$15.14M$-22.77M$-20.85M$-37.95M$-92.47M$-164.44M$-271.39M$-289.40M$-245.19M$-235.26M$-281.58M$-167.87M$-215.97M$-61.29M$226.45M$391.00M
Net income growth (YoY)-25.2%-13.9%+29.7%+133.5%-250.4%+8.4%-82.0%-143.7%-77.8%-65.0%-6.6%+15.3%+4.1%-19.7%+40.4%-28.7%+71.6%+469.5%+72.7%
Profit margin-553.9%-746.4%-4040.5%-705.5%35.9%-1101.4%-424.9%-3314.2%-77062.5%-269578.7%-1565.9%-231.7%-109.6%-69.4%-63.7%-34.7%-41.8%-8.4%23.6%36.5%